<DOC>
	<DOCNO>NCT00106366</DOCNO>
	<brief_summary>This trial conduct United States America ( USA ) . The purpose study determine use insulin detemir combination insulin aspart safe least effective insulin glargine combination insulin aspart control blood glucose patient Type 2 diabetes .</brief_summary>
	<brief_title>Comparison Insulin Detemir With Insulin Glargine Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Detemir</mesh_term>
	<mesh_term>Insulin Aspart</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<criteria>Type 2 Diabetes 12 month Currently treat glucose lower tablet insulin HbA1c : 7.012.0 %</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Diabetes , Type 2</keyword>
</DOC>